{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:06:35Z","timestamp":1758636395409,"version":"3.41.2"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Thalassemia is the commonest hemoglobinopathy in Southeast Asia. Kidney dysfunction is an underreported sequelae in children with thalassemia. We conducted a retrospective study to identify the prevalence of and predisposing factors for kidney dysfunction in children with transfusion-dependent thalassemia (TDT).<\/jats:p><jats:p><jats:bold>Method:<\/jats:bold> Abnormal kidney function was defined as children with a glomerular filtration rate (GFR) of &amp;lt;90 ml\/min\/1.73 m<jats:sup>2<\/jats:sup> or a decline in GFR of &amp;gt;20 ml\/min\/1.73 m<jats:sup>2<\/jats:sup> or presence of nephrotic range proteinuria within 3 years of commencing regular (every \u22646 weeks) red cell transfusion. Data analyzed were age at diagnosis of thalassemia, number of transfusion-years, iron chelation therapy, serum ferritin, and pre-transfusion hemoglobin levels.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Eighty-one children were studied. Mean age was 11.72 \u00b1 5.275 years. Thirty out of 81 (37%) demonstrated abnormal kidney function. Evidence of glomerular hyperfiltration was seen in 29\/81 patients (25.85%) at their last clinic visit. This fraction was doubled [48\/81 (59.3%)] when the cohort was tracked back by 3 years from the last clinic encounter. Age at diagnosis (RR, 1.157; 95% CI, 1.014\u20131.319; <jats:italic>p<\/jats:italic> = 0.03) and duration of receiving transfusions (RR, 0.984; 95% CI, 0.974\u20130.994; <jats:italic>p<\/jats:italic> = 0.001) were associated with increased risk of developing abnormal kidney function.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Abnormal kidney function in children with TDT may be overlooked by medical personnel without active screening measures. Children receiving regular red cell transfusions require systematic surveillance to enable early detection of kidney dysfunction and timely implementation of appropriate therapeutic interventions.<\/jats:p>","DOI":"10.3389\/fped.2021.754813","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T10:48:50Z","timestamp":1637578130000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Occult Kidney Dysfunction in Children With Transfusion-Dependent Thalassemia"],"prefix":"10.3389","volume":"9","author":[{"given":"Nurwahida","family":"Mohd Zikre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nor A.","family":"Muhamad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline S. Y.","family":"Eng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nur E.","family":"Zailanalhuddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles D.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jen C.","family":"Foo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suet L.","family":"Yap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hany","family":"Ariffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karmila","family":"Abu Bakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e037974","DOI":"10.1136\/bmjopen-2020-037974","article-title":"Observational study on the current status of thalassaemia in Malaysia: a report from the Malaysian Thalassaemia Registry","volume":"10","author":"Mohd Ibrahim","year":"2020","journal-title":"BMJ Open."},{"key":"B2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/bjaceaccp\/mkl053","article-title":"Complications of blood transfusion","volume":"6","author":"Maxwell","year":"2006","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"key":"B3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/ajh.20809","article-title":"Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: a report from the multi-center study of iron overload","volume":"82","author":"Fung","year":"2007","journal-title":"Am J Hematol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.bbagen.2008.09.010","article-title":"Iron overload following red blood cell transfusion and its impact on disease severity","volume":"1790","author":"Ozment","year":"2009","journal-title":"Biochim Biophys Acta."},{"key":"B5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12947-019-0174-y","article-title":"Global longitudinal strain as an Indicator of cardiac Iron overload in thalassemia patients","volume":"17","author":"Abtahi","year":"2019","journal-title":"Cardiovasc Ultrasound."},{"key":"B6","first-page":"158","article-title":"Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre","volume":"6","author":"Gamberini","year":"2008","journal-title":"Pediatr Endocrinol Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cccn.2003.07.010","article-title":"Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia","volume":"338","author":"Kassab-Chekir","year":"2003","journal-title":"Clin Chim Acta."},{"key":"B8","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00467-008-0753-x","article-title":"Early markers of renal dysfunction in patients with beta-thalassemia major","volume":"23","author":"Mohkam","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejrad.2018.04.007","article-title":"Renal iron deposition by magnetic resonance imaging in pediatric \u03b2-thalassemia major patients: relation to renal biomarkers, total body iron and chelation therapy","volume":"103","author":"El Alfy","year":"2018","journal-title":"Eur J Radiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"c136","DOI":"10.1159\/000339787","article-title":"Glomerular hyperfiltration and proteinuria in transfusion-independent patients with beta-thalassemia intermedia","volume":"121","author":"Ziyadeh","year":"2012","journal-title":"Nephron Clin Pract."},{"key":"B11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00277-015-2561-2","article-title":"Documentation of renal glomerular and tubular impairment and glomerular hyperfiltration in multitransfused patients with beta thalassemia","volume":"95","author":"Deveci","year":"2016","journal-title":"Ann Hematol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.12816\/0003341","article-title":"Frequency of glomerular dysfunction in children with beta thalassaemia major","volume":"14","author":"Ali","year":"2014","journal-title":"Sultan Qaboos Univ Med J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"17088","DOI":"10.1038\/nrdp.2017.88","article-title":"Chronic kidney disease","volume":"3","author":"Romagnani","year":"2017","journal-title":"Nat Rev Dis Primers."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1093\/ndt\/gfs169","article-title":"Renal function in patients with \u03b2-thalassaemia major: a long-term follow-up study","volume":"27","author":"Lai","year":"2012","journal-title":"Nephrol Dial Transplant."},{"key":"B15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1681\/asn.2005070757","article-title":"Chronic hypoxia and tubulointerstitial injury : a final common pathway to end-stage renal failure","volume":"17","author":"Nangaku","year":"2006","journal-title":"J Am Soc Nephrol."},{"volume-title":"Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT)","year":"2014","author":"Cappellini","key":"B16"},{"key":"B17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000287238","article-title":"Renal dysfunction in patients with beta-thalassemia major receiving iron chelation therapy either with deferoxamine and deferiprone or with deferasirox","volume":"123","author":"Economou","year":"2010","journal-title":"Acta Haematol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1365-2141.2006.06455.x","article-title":"A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease","volume":"136","author":"Vichinsky","year":"2007","journal-title":"Br J Haematol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/s0272-6386(82)80091-7","article-title":"Clinical appraisal of creatinine clearance as a measurement of glomerular filtration rate","volume":"2","author":"Bauer","year":"1982","journal-title":"Am J Kidney Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"424","DOI":"10.5863\/1551-6776-23.6.424","article-title":"Glomerular filtration rate estimation formulas for pediatric and neonatal use","volume":"23","author":"Muhari-Stark","year":"2018","journal-title":"J Pediatr Pharmacol Ther"},{"key":"B21","doi-asserted-by":"publisher","first-page":"382","DOI":"10.2215\/CJN.03080314","article-title":"A systematic review of glomerular hyperfiltration assessment and definition in the medical literature","volume":"10","author":"Cachat","year":"2015","journal-title":"Clin J Am Soc Nephrol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1038\/labinvest.3780200","article-title":"Association of renal injury with increased oxygen free radical activity and altered nitric oxide metabolism in chronic experimental hemosiderosis","volume":"80","author":"Zhou","year":"2000","journal-title":"Lab Invest."},{"key":"B23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3109\/15513818909026908","article-title":"Renal lesions and clinical findings in thalassemia major and other chronic anemias with hemosiderosis","volume":"9","author":"Landing","year":"1989","journal-title":"Pediatr Pathol"},{"key":"B24","first-page":"517","article-title":"Effects of growth hormone and insulin-like growth factor-I on the iron-induced lipid peroxidation in the rat liver and porcine thyroid homogenates","volume":"31","author":"Kokoszko","year":"2010","journal-title":"Neuro Endocrinol Lett."},{"key":"B25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.blre.2010.08.004","article-title":"Renal complications in transfusion-dependent beta thalassaemia","volume":"24","author":"Ponticelli","year":"2010","journal-title":"Blood Rev."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1182\/blood-2005-08-3430","article-title":"A phase III study of deferasirox (ICL670), a once daily oral iron chelator, in patients with \u03b2-thalassaemia","volume":"107","author":"Cappellini","year":"2006","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1681\/asn.2011111070","article-title":"Mechanisms of renal disease in \u03b2-thalassemia","volume":"23","author":"Musallam","year":"2012","journal-title":"J Am Soc Nephrol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/ki.1994.295","article-title":"Early detection of nephrotoxic effects in thalassemic patients receiving desferrioxamine therapy","volume":"46","author":"Cianciulli","year":"1994","journal-title":"Kidney Int"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1001\/archpedi.1989.02150210113029","article-title":"Acute changes in renal function associated with deferoxamine therapy","volume":"143","author":"Koren","year":"1989","journal-title":"Am J Dis Child."},{"key":"B30","first-page":"514","article-title":"Acute renal failure occurring during intravenous desferrioxamine therapy: recovery after haemodialysis","volume":"77","author":"Cianciulli","year":"1992","journal-title":"Haematologica"},{"key":"B31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12882-015-0072-y","article-title":"Chronic kidney disease is common in sickle cell disease: a cross-sectional study in the Tema Metropolis, Ghana","volume":"16","author":"Ephraim","year":"2015","journal-title":"BMC Nephrol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1038\/ki.1996.265","article-title":"The hyperfiltration theory: a paradigm shift in nephrology, Kidney Int","volume":"49","author":"Brenner","year":"1996"},{"key":"B33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1365-2141.2010.08477.x","article-title":"Renal dysfunction in patients with thalassaemia","volume":"153","author":"Quinn","year":"2011","journal-title":"Br J Haematol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.5493\/wjem.v4.i3.38","article-title":"Oxidative stress and labile plasmatic iron in anemic patients following blood therapy","volume":"4","author":"Fernandes","year":"2014","journal-title":"World J Exp Med."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.754813\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T10:48:56Z","timestamp":1637578136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.754813\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,22]]},"references-count":34,"alternative-id":["10.3389\/fped.2021.754813"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.754813","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2021,11,22]]},"article-number":"754813"}}